Matching placebo to pioglitazone

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Type 2 Diabetes Mellitus

Phase 3

A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)

CompletedNCT00541450

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2008-01-15End: 2010-01-16Updated: 2017-05-12

MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)

CompletedNCT00722371

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2008-09-05End: 2011-03-25Updated: 2017-05-12